DNLI

Question 1

Who is the CEO of Denali Therapeutics Inc?

Accepted Answer

Dr. Ryan Watts is the President of Denali Therapeutics Inc, joining the firm since 2015.

Question 2

What is the price performance of DNLI stock?

Accepted Answer

The current price of DNLI is $16.99, it has decreased 0% in the last trading day.

Question 3

What are the primary business themes or industries for Denali Therapeutics Inc?

Accepted Answer

Denali Therapeutics Inc belongs to Biotechnology industry and the sector is Health Care

Question 4

What is Denali Therapeutics Inc market cap?

Accepted Answer

Denali Therapeutics Inc's current market cap is $2.4B

Question 5

Is Denali Therapeutics Inc a buy, sell, or hold?

Accepted Answer

According to wall street analysts, 15 analysts have made analyst ratings for Denali Therapeutics Inc, including 11 strong buy, 13 buy, 1 hold, 0 sell, and 11 strong sell

Denali Therapeutics Inc (DNLI) Price

DNLI Stock Price Chart

Related News

Denali Secures $275M Royalty Deal for Hunter Syndrome Drug

Follow-Up Questions

Who is the CEO of Denali Therapeutics Inc?

What is the price performance of DNLI stock?

What are the primary business themes or industries for Denali Therapeutics Inc?

What is Denali Therapeutics Inc market cap?

Is Denali Therapeutics Inc a buy, sell, or hold?

Related News

Denali Secures $275M Royalty Deal for Hunter Syndrome Drug

Follow-Up Questions

Who is the CEO of Denali Therapeutics Inc?

What is the price performance of DNLI stock?

What are the primary business themes or industries for Denali Therapeutics Inc?

What is Denali Therapeutics Inc market cap?

Is Denali Therapeutics Inc a buy, sell, or hold?